Medicare part D's effects on elderly patients' drug costs and utilization

American Journal of Managed Care

Volumn 14, Issue 11 SPEC. ISS., 2008, Pages

  Ketcham, Jonathan D ^a,c   Simon, Kosali I ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; HEALTH; HUMAN; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL;

AGED; DRUG UTILIZATION; HUMANS; MEDICARE PART D; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES;

EID: 56749095516     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The Henry J. Kaiser Family Foundation. The Medicare Prescription Drug Benefit Fact Sheet. November 2006. The Henry J. Kaiser Family Foundation publication 7044-05. http://www.kff.org/medicare/upload/7044- 05.pdf. Accessed October 2, 2008.
2. The Henry J. Kaiser Family Foundation. The Medicare Prescription Drug Benefit Fact Sheet. October 2007. The Henry J. Kaiser Family Foundation publication 7044-07. http://www.kff.org/medicare/upload/ 7044_07.pdf. Accessed October 2, 2008.
3. Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148(3):169-177.
4. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood). 2007;26(6):1735-1744.
5. Levy H, Weir D. Take-up of Medicare Part D and the SSA subsidy: early results from the Health and Retirement Study. October 2007. Michigan Retirement Research Center research paper WP 2007-163. http://papers.ssrn.com/ sol3/papers.cfm?abstract_id=1082832. Accessed October 2, 2008.
6. Neuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood). 2007;26(5):w630-w643. Epub 2007 Aug 21.
7. Pauly MV. Medicare drug coverage and moral hazard. Health Aff (Millwood). 2004;23(1):113-122.
8. Wolters Kluwer Health. Source® Lx. December 2004-December 2007. http://www.wkhealth.com/pt/re/ps/source.htm. Accessed October 20, 2008.
9. US Census Bureau. U.S. interim projections by age, sex, race, and Hispanic origin: 2000-2050. http://www.census.gov/ipc/www/usinterimproj/. Accessed October 2, 2008.
10. US Census Bureau. National population estimates for the 2000s. Monthly postcensal resident population, by single year of age, sex, race, and Hispanic origin. http://www.census.gov/popest/national/asrh/2007-nat-res.html. Accessed October 2, 2008.
11. Wolters Kluwer Health. Source® Pharmaceutical Audit Suite Tool. http://www.wkhealth.com/pt/re/ps/source.htm. Accessed October 20, 2008.
12. National Council for Prescription Drug Programs. Data on pharmacy locations. October 2007. http://www.ncpdp.org. Accessed October 2, 2008.
13. Merrick A. Getting an A in Part D. The Wall Street Journal. June 21, 2006:B1.
14. Frederick J. Walgreen looks for big gains as Medicare spurs PBM growth. Drug Store News. July 11, 2005. http://findarticles.com/p/ articles/mi_m3374/is_9_27/ai_n14812274/pg_1. Accessed June 2, 2008.
15. Broad initiatives steer patients through Part D traffic. Drug Store News. March 20, 2006. http://findarticles.com/p/articles/mi_m3374/ is_4_28/ai_n16114814. Accessed June 2, 2008.
16. Walgreens offers support evaluating Medicare Part D plans. November 14, 2007. http://news.walgreens.com/article_display.cfm?article_id= 4882. Accessed June 2, 2008.
17. Lichtenberg FR, Sun SX. The impact of Medicare Part D on prescription drug use by the elderly: evidence from a large retail pharmacy chain. Columbia University, National Bureau of Economic Research, and Walgreens Health Services. January 29, 2007. Working paper.
18. Surveillance Data Inc. Verispan VONA prescription sales audit. 2008. http://www.sdihealth.com/Verispan/VectorOne.aspx. Accessed October 2, 2008.
19. McClellan M, Skinner J. The incidence of Medicare. J Pub Econ. 2006;90:257-276.
20. Bhattacharya J, Lakdawalla D. The incidence of Medicare. J Pub Econ. 2006;90:277-292.
21. Epstein AJ, Rathore SS, Alexander GC, Ketcham JD. Primary care physicians' views of Medicare Part D. Am J Manag Care. 2008;14(11 Spec No.):SP5-SP13.
22. Goldman D, Philipson T. Integrated insurance design in the presence of multiple medical technologies. January 2007. National Bureau of Economic Research working paper 12870. http://www.nber.org/papers/w12870. Accessed October 2, 2008.
23. Lichtenberg FR. Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003. May 2008. National Bureau of Economic Research working paper 14008. http://www.nber.org/papers/w14008. Accessed October 2, 2008.
24. Duggan M, Scott-Morton F. The effect of Medicare Part D on pharmaceutical prices and utilization. April 2008. http://www.nber.org/papers/ w13917. National Bureau of Economic Research working paper 13917. Accessed October 2, 2008.
25. Blume-Kohout ME, Sood N. The impact of Medicare Part D on pharmaceutical R&D. March 2008. National Bureau of Economic Research working paper 13857. http://www.nber.org/papers/w13857. Accessed October 2, 2008.